GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.80
-0.15 (-0.75%)
May 9, 2025, 12:45 PM CST

GeneReach Biotechnology Company Description

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan.

The company offers automatic nucleic acid extraction systems, prep homogenization system, and mini centrifuge equipment; and reagents and consumables, comprising human IVD assays, iiPCR specific reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and research reagents and consumables.

It also provides polymerase chain reaction training programs (PCR), molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services.

It serves aquaculture, agriculture, food, and human health industries, as well as companion animals and livestock.

The company was founded in 2004 and is headquartered in Taichung, Taiwan.

GeneReach Biotechnology Corp.
Country Taiwan
Founded 2004
Industry Biotechnology
Sector Healthcare
CEO Grace Chang

Contact Details

Address:
Central Science Park
Taichung, 407
Taiwan
Phone 886 4 2463 9869
Website genereach.com

Stock Details

Ticker Symbol 4171
Exchange Taipei Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004171004
SIC Code 2835

Key Executives

Name Position
Zhengzhong Liu MSc Chairman of the Board and Head of Public Relations
David Tsai Ph.D. Chief Operation Officer
Shuyu Cao Accounting Supervisor
Yu-Wen Huang Vice President of Compliance and Production Department